Client News
Filter by:
- Feb 4 2019 NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials
- Jan 30 2019 ClearSign Names Colin James Deller, Ph.D. as President, to transition to Chief Executive Officer
- Jan 29 2019 Bion Files for International Patent on Process to Remediate Livestock Waste/ Produce Organic Fertilizer
- Jan 25 2019 Making an Impact at MusclePharm
- Jan 24 2019 Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board
- Jan 15 2019 Diego Pellicer Worldwide, Inc. CEO Featured For His Cannabis Expertise By National Business Media
- Jan 14 2019 CytRx Corporation Highlights Aldoxorubicin's Inclusion In New NantCell Inc. Colorectal Cancer Clinical Trial
- Jan 11 2019 Endonovo Therapeutics Issues Shareholder Letter and Update
- Jan 8 2019 ClearSign and Anthony DiGiandomenico Reach Agreement to Refresh ClearSign's Board and Ensure Smooth Management Transition
- Jan 3 2019 Endonovo Therapeutics Enters into $10 million Common Stock Purchase Agreement with Azure Capital